Xilio Therapeutics annual operating margin
2024
2025
Xilio Therapeutics Operating Margin Growth & History (XLO)
Xilio Therapeutics's operating margin was −95.92% for fiscal 2025.
View full Xilio Therapeutics company overviewXilio Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −95.92% | +859.03 pp |
| 2024 | 2024-12-31 | −954.95% | — |
Xilio Therapeutics quarterly operating margin
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −18.68% | +159.03 pp |
| Q1 2026 | 2026-03-31 | −111.57% | +361.16 pp |
| Q4 2025 | 2025-12-31 | −86.48% | — |
| Q3 2025 | 2025-09-30 | −10.12% | +642.20 pp |
| Q2 2025 | 2025-06-30 | −177.71% | +446.13 pp |
| Q1 2025 | 2025-03-31 | −472.73% | — |
| Q3 2024 | 2024-09-30 | −652.32% | — |
| Q2 2024 | 2024-06-30 | −623.84% | — |
Xilio Therapeutics operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Xilio Therapeutics's operating margin increased from −954.95% to −95.92%, a change of +859.03 percentage points. The latest reported quarter, Q2 2026, shows −18.68%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xilio Therapeutics source filings ↗